López-Arnau R, Luján M A, Duart-Castells L, Pubill D, Camarasa J, Valverde O, Escubedo E
Department of Pharmacology and Therapeutic Chemistry, Pharmacology Section and Institute of Biomedicine (IBUB), Faculty of Pharmacy, University of Barcelona, Barcelona, Spain.
Neurobiology of Behaviour Research Group (GReNeC-NeuroBio), Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
Br J Pharmacol. 2017 May;174(10):1161-1173. doi: 10.1111/bph.13771. Epub 2017 Apr 6.
3,4-Methylenedioxypyrovalerone (MDPV) is a synthetic cathinone with powerful psychostimulant effects. It selectively inhibits the dopamine transporter (DAT) and is 10-50-fold more potent as a DAT blocker than cocaine, suggesting a high abuse liability. The main objective of the present study was to assess the consequences of an early (adolescence) MDPV exposure on the psychostimulant, rewarding and reinforcing effects induced by cocaine in adult mice.
Twenty-one days after MDPV pretreatment (1.5 mg·kg , s.c., twice daily for 7 days), adult mice were tested with cocaine, using locomotor activity, conditioned place preference and self-administration (SA) paradigms. In parallel, dopamine D receptor density and the expression of c-Fos and ΔFosB in the striatum were determined.
MDPV treatment enhanced the psychostimulant and conditioning effects of cocaine. Acquisition of cocaine SA was unchanged in mice pretreated with MDPV, whereas the breaking point achieved under a progressive ratio programme and reinstatement after extinction were higher in this group of mice. MDPV decreased D receptor density but increased ΔFosB expression three-fold. As expected, acute cocaine increased c-Fos expression, but MDPV pretreatment negatively influenced its expression. ΔFosB accumulation declined during MDPV withdrawal, although it remained elevated in adult mice when tested for cocaine effects.
MDPV exposure during adolescence induced long-lasting adaptive changes related to enhanced responsiveness to cocaine in the adult mice that seems to lead to a higher vulnerability to cocaine abuse. This particular behaviour correlated with increased expression of ΔFosB.
3,4-亚甲基二氧吡咯戊酮(MDPV)是一种具有强大精神兴奋作用的合成卡西酮。它选择性抑制多巴胺转运体(DAT),作为DAT阻滞剂,其效力比可卡因强10至50倍,提示其具有很高的滥用可能性。本研究的主要目的是评估成年小鼠在青春期早期接触MDPV对可卡因诱导的精神兴奋、奖赏和强化作用的影响。
MDPV预处理(1.5毫克·千克,皮下注射,每天两次,共7天)21天后,使用运动活动、条件性位置偏爱和自身给药(SA)范式对成年小鼠进行可卡因测试。同时,测定纹状体中多巴胺D受体密度以及c-Fos和ΔFosB的表达。
MDPV处理增强了可卡因的精神兴奋和条件化作用。MDPV预处理的小鼠获得可卡因SA的情况未发生变化,而在渐进比率程序下达到的断点以及消退后的恢复情况在该组小鼠中更高。MDPV降低了D受体密度,但使ΔFosB表达增加了三倍。正如预期的那样,急性可卡因增加了c-Fos表达,但MDPV预处理对其表达产生了负面影响。在MDPV戒断期间,ΔFosB积累减少,尽管在对可卡因效应进行测试时,成年小鼠体内的ΔFosB水平仍保持升高。
青春期接触MDPV会在成年小鼠中诱导与对可卡因反应性增强相关的持久适应性变化,这似乎导致对可卡因滥用的更高易感性。这种特殊行为与ΔFosB表达增加相关。